FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.
March 25, 2025) - A class-action lawsuit has been filed against the medical technology company, which specializes in organ transplant therapy, alleging that the company and certain executives engaged ...
13h
Zacks Investment Research on MSNDropbox (DBX) Outperforms Broader Market: What You Need to KnowIn the latest trading session, Dropbox (DBX) closed at $27.24, marking a +0.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.16%. Meanwhile, the ...
Desktop Metal has secured a legal victory in its merger dispute with Nano Dimension. Nano shares are lower by some 16% ...
Trump Media & Technology Group shares jumped 8.4% to $22.76 on Tuesday. Here are some other big stocks recording gains in ...
22h
TipRanks on MSNHouston We Have a Problem! Dropbox Stock (DBX) Slips as Hedge Fund Moves to Curb Chief’s ControlThe skies darkened for cloud storage provider Dropbox ($DBX) today on reports that an activist investor wants to curb the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results